Sciences and medicine will converge
RETHINK, July 10, 2019. Dr. James Bradner, President of the Novartis Institutes for BioMedical Research (NIBR), visited ETH Zurich. He gave an inspiring ETH Global lecture, co-hosted by RETHINK. This highly recognized lecture series provides an opportunity to discuss the pressing questions of our time and learn from distinguished leaders in their field. Addressing the audience in the fully booked Siemes Auditorium, Dr. Bradner explained what it means for NIBR to shape the future of healthcare and charting a new course for collaboration with academic partners around the world.